View in EDS HTML Full Text PDF Full Text

Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin.

Saved in:
Bibliographic Details
Title: Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin.
Authors: Gorodnova, Tatiana V.1 (AUTHOR), Sokolenko, Anna P.1,2 (AUTHOR), Kotiv, Khristina B.1 (AUTHOR), Sokolova, Tatiana N.1 (AUTHOR), Ivantsov, Alexandr O.1,2 (AUTHOR), Guseynov, Konstantin D.1 (AUTHOR), Nekrasova, Ekaterina A.1 (AUTHOR), Smirnova, Olga A.1 (AUTHOR), Berlev, Igor V.1,3 (AUTHOR), Imyanitov, Evgeny N.1,2,3 (AUTHOR) evgeny@imyanitov.spb.ru
Source: Hereditary Cancer in Clinical Practice. 2/3/2021, Vol. 19 Issue 1, p1-7. 7p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17312302
DOI:10.1186/s13053-021-00173-2